Resmetirom
Last Updated: 02/24/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 325 publications
Lactiplantibacillus plantarum Q180 Supplementation Restores High-Fat Diet-Induced Gut Dysbiosis and Intestinal Barrier Dysfunction in Mice.
Journal: Journal of applied microbiology
Published: January 23, 2026
Targeting THR-β for MASLD Treatment: Current Progression and Emerging Prospects.
Journal: Journal of medicinal chemistry
Published: January 06, 2026
Screening and management of metabolic dysfunction-associated steatotic liver disease (MASLD).
Journal: JAAPA : official journal of the American Academy of Physician Assistants
Published: December 10, 2025
Is the combination of resmetirom and semaglutide useful for the treatment of metabolic dysfunction-associated steatohepatitis?
Journal: Diabetes, obesity & metabolism
Published: December 07, 2025
Current Update on Nomenclature, Diagnosis, and Management of Metabolic Dysfunction-associated Steatotic Liver Disease: Radiologists' Perspective.
Journal: Radiographics : a review publication of the Radiological Society of North America, Inc
Published: November 13, 2025
Optimized MASH treatment eligibility cutoffs for MRE-measured liver stiffness and proton density fat fraction.
Journal: Clinical and molecular hepatology
Published: November 10, 2025
Metabolic Dysfunction-Associated Steatotic Liver Disease in Adults: A Review.
Journal: JAMA
Published: November 10, 2025
Cost-Effectiveness of MASH Diagnosis and Management Approaches Among Those With Type 2 Diabetes.
Journal: JAMA network open
Published: November 06, 2025
Semaglutide therapy for metabolic dysfunction-associated steatohepatitis: November 2025 updates to AASLD Practice Guidance.
Journal: Hepatology (Baltimore, Md.)
Published: October 31, 2025
Effects of Resmetirom on Resistance to Thyroid Hormone Receptor Mutants: Potential Basis for Therapeutic Applications.
Journal: Biological & pharmaceutical bulletin
Published: October 29, 2025
Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis: A Narrative Review.
Journal: Cureus
Published: October 25, 2025
A gut-liver lipid flux checkpoint mediates FAHFA protection from MASLD.
Journal: Pharmacological research
Published: October 22, 2025
Last Updated: 02/24/2026